Trial Profile
Study of Safety and Efficacy of Eltrombopag Maintainance Therapy in Patients After an Induction Treatment with Eltrombopag 50 mg Orally Once Daily.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 27 May 2015 New trial record